These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27479569)

  • 1. Dengue vaccine and the 2016 Olympics.
    Halstead SB; Aguiar M
    Lancet; 2016 Jul; 388(10041):237-8. PubMed ID: 27479569
    [No Abstract]   [Full Text] [Related]  

  • 2. ADE and dengue vaccination.
    Martínez-Vega RA; Carrasquila G; Luna E; Ramos-Castañeda J
    Vaccine; 2017 Jul; 35(32):3910-3912. PubMed ID: 28623027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addendum to report of the Global Advisory Committee on Vaccine Safety (GACVS), 10-11 June 2015¹. Safety of CYD-TDV dengue vaccine.
    Wkly Epidemiol Rec; 2015 Aug; 90(34):421-3. PubMed ID: 26298882
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety concerns derail dengue vaccination program.
    Normile D
    Science; 2017 Dec; 358(6370):1514-1515. PubMed ID: 29269451
    [No Abstract]   [Full Text] [Related]  

  • 5. Dengue Vaccine: Considerations before Rollout in Colombia.
    Villabona-Arenas CJ; Ocazionez Jimenez RE; Jimenez Silva CL
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004653. PubMed ID: 27280803
    [No Abstract]   [Full Text] [Related]  

  • 6. Mosquito control might not bolster imperfect dengue vaccines.
    Paul R; Sousa C; Sakuntabhai A; Devine G
    Lancet; 2014 Nov; 384(9956):1747-8. PubMed ID: 25455246
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru.
    Lanata CF; Andrade T; Gil AI; Terrones C; Valladolid O; Zambrano B; Saville M; Crevat D
    Vaccine; 2012 Sep; 30(41):5935-41. PubMed ID: 22863660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity.
    Poo J; Galan F; Forrat R; Zambrano B; Lang J; Dayan G
    Pediatr Infect Dis J; 2011 Jan; 30(1):e9-17. PubMed ID: 21042231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines.
    Capeding RZ; Luna IA; Bomasang E; Lupisan S; Lang J; Forrat R; Wartel A; Crevat D
    Vaccine; 2011 May; 29(22):3863-72. PubMed ID: 21477675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence?
    Gessner BD; Halsey N
    Vaccine; 2017 Jun; 35(27):3452-3456. PubMed ID: 28528764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneities in dengue spatial-temporal transmission in Brazilian cities and its influence on the optimal age of vaccination.
    Cardim LL; Pinho STR; Teixeira MG; Costa MCN; Esteva ML; Ferreira CP
    BMC Public Health; 2019 Feb; 19(1):155. PubMed ID: 30727988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue vaccination: a more balanced approach is needed.
    Pang T; Gubler D; Goh DYT; Ismail Z;
    Lancet; 2018 Feb; 391(10121):654. PubMed ID: 29617262
    [No Abstract]   [Full Text] [Related]  

  • 13. Sanofi’s successful Phase 3 trials may lead to first-ever dengue vaccine in 2015.
    Hum Vaccin Immunother; 2014; 10(12):3427. PubMed ID: 25864560
    [No Abstract]   [Full Text] [Related]  

  • 14. Trolleyology and the Dengue Vaccine Dilemma.
    Rosenbaum L
    N Engl J Med; 2018 Jul; 379(4):305-307. PubMed ID: 29898371
    [No Abstract]   [Full Text] [Related]  

  • 15. Designing a vaccination strategy against dengue.
    Amaku M; Coudeville L; Massad E
    Rev Inst Med Trop Sao Paulo; 2012 Oct; 54 Suppl 18():S18-21. PubMed ID: 23011455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue transmission during the 2014 FIFA World Cup in Brazil.
    Aguiar M; Coelho GE; Rocha F; Mateus L; Pessanha JE; Stollenwerk N
    Lancet Infect Dis; 2015 Jul; 15(7):765-6. PubMed ID: 26122446
    [No Abstract]   [Full Text] [Related]  

  • 17. Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.
    Normile D
    Science; 2007 Sep; 317(5844):1494-5. PubMed ID: 17872423
    [No Abstract]   [Full Text] [Related]  

  • 18. Critique of World Health Organization Recommendation of a Dengue Vaccine.
    Halstead SB
    J Infect Dis; 2016 Dec; 214(12):1793-1795. PubMed ID: 27496975
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
    Capeding MR; Tran NH; Hadinegoro SR; Ismail HI; Chotpitayasunondh T; Chua MN; Luong CQ; Rusmil K; Wirawan DN; Nallusamy R; Pitisuttithum P; Thisyakorn U; Yoon IK; van der Vliet D; Langevin E; Laot T; Hutagalung Y; Frago C; Boaz M; Wartel TA; Tornieporth NG; Saville M; Bouckenooghe A;
    Lancet; 2014 Oct; 384(9951):1358-65. PubMed ID: 25018116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
    Hadinegoro SR; Arredondo-García JL; Capeding MR; Deseda C; Chotpitayasunondh T; Dietze R; Muhammad Ismail HI; Reynales H; Limkittikul K; Rivera-Medina DM; Tran HN; Bouckenooghe A; Chansinghakul D; Cortés M; Fanouillere K; Forrat R; Frago C; Gailhardou S; Jackson N; Noriega F; Plennevaux E; Wartel TA; Zambrano B; Saville M;
    N Engl J Med; 2015 Sep; 373(13):1195-206. PubMed ID: 26214039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.